Skip to main content
HighlightsHighlights Archive

Dementia biomarkers identified as hopes rise for early blood test

The discovery of new biomarkers have given researchers hope that a blood test can be developed which can detect dementia in patients up to ten years earlier than a formal diagnosis. The developments were made following analysis of samples from the 50,000 healthy individuals who are participating in the UK Biobank project. Examination of the blood revealed patterns of four…
Dawn
February 14, 2024
HighlightsHighlights Archive

Media Monitoring: 8 – 14 February

Simple sponge test can prevent cancer that ‘hides in plain sight’ An innovative test which can prevent cancer deaths needs to be made more widely available, a cancer charity has warned. The capsule sponge test collects cells from the oesophagus and can detect abnormalities which make a person more likely to develop oesophageal cancer. If oesophageal cancer is detected early…
Ben Kemp
February 14, 2024
HighlightsHighlights Archive

Media Monitoring: 1 February – 7 February

MHRA announces two new UK Approved Bodies to certify medical devices LNE-GMED UK and Scarlet NB UK join the seven current UK Approved Bodies, increasing capacity for the certification of medical devices in the UK. LNE-GMED UK has been designated as a UK Approved Body to assess and certify general medical devices in accordance with Part II of the UK Medical…
Dawn
February 7, 2024
HighlightsHighlights Archive

Labour unveils new Life Sciences sector plan

  Last week, the Shadow Health Secretary Wes Streeting and the Shadow Science, Innovation and Technology Secretary Peter Kyle revealed Labour’s plans for the life sciences sector should they form the next Government. During the unveiling, the Shadow Secretaries declared that the NHS should be ‘an engine for innovation for our country’ and ‘the latest wave of technology can transform…
Dawn
February 7, 2024
HighlightsHighlights Archive

British scientists make cancer blood test breakthrough

British scientists have pioneered a new blood test which can diagnose certain types of brain cancer. As well as being simple and inexpensive, it could in some cases reduce the need for risky, invasive surgeries. The test could also provide earlier diagnoses, speeding up access to treatment and therefore increasing survival rates. Experts believe the test could be introduced into…
Ben Kemp
January 31, 2024
HighlightsHighlights Archive

First patients with inherited blood disorders to get world-first NHS test to curb transfusion side effects

From this week, thousands of people with sickle cell disorder and thalassaemia in England will have access a world-first ‘blood matching’ genetic test on the NHS to better match their blood transfusions, reducing the risk of side effects and offering more personalised care. The NHS becomes the first healthcare system in the world to provide a new blood group genotyping…
Dawn
January 31, 2024
HighlightsHighlights Archive

Media Monitoring: 25 – 31 January

Warnings of bare R+D pipeline for top pathogens with pandemic potential, as latest 100 Days Mission report launched New analysis reveals limited approved tests, treatments and vaccines for WHO priority pathogens, except COVID-19 and Ebola Zaire. Progress made in vaccines R&D in 2023, but diagnostics and therapeutics underfunded and lagging. Partners come together in Rome as Italy’s G7 Presidency gets…
Dawn
January 31, 2024
HighlightsHighlights Archive

UKHSA release 5-year Pathogen Genomics Strategy

The UK Health Security Agency (UKHSA) has published its Pathogen Genomics Strategy, laying out a 5 year plan for the organisation’s role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health. The new strategy sets out a programme to improve UKHSA’s ability to detect and understand the pathogens that pose the…
Dawn
January 31, 2024